Sera Prognostics Overview
Latest P/E ratio for Sera Prognostics: -3.14 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-3.14
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
As of the most recent data, SERA shows a P/E ratio of -3.14. That is below the Healthcare sector average of 27.42. Scroll down for historical charts and peer comparison views.
The Healthcare sector average P/E ratio is about 27.42. Sera Prognostics is at -3.14, which is lower that average. That is roughly 111.4% below the sector mean. Use the comparison chart on this page to see how SERA stacks up against individual peers as well.
Investors watch SERA's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Sera Prognostics's latest reading is -3.14. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this p/e ratio page, Stockcircle has Sera Prognostics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently -3.14) with ownership activity and broader fundamentals.
The Healthcare average P/E ratio is about 27.42, while SERA is at -3.14. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
